Navigation Links
Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
Date:1/17/2008

EXTON, Pa., Jan. 17 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum at the Ritz-Carlton in Palm Beach, Florida on Wednesday, January 23, 2008.

Wendy F. DiCicco, Kensey Nash's CFO, will deliver the Company's presentation, beginning at approximately 9:05 a.m. (ET). The presentation materials will be available on the company's website (http://www.kenseynash.com) beginning at 9:05 a.m. (ET) on Wednesday, January 23, 2008.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
2. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
3. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
4. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
5. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
6. Siemens Building Technologies Helping Companies Participate in EPA Labs21 Movement With Comprehensive Compliance Solution Strategy
7. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
8. Ardea Biosciences to Participate in RBC Capital Markets 2007 Healthcare Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
11. Angiotech to participate in Bank of America 2007 Credit Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2018)... ... ... Helping conclude Healthy Aging Month this past September, Signia partners with Mediaplanet ... and Hearing campaign that sets out to shed light on various ways to help ... destigmatize hearing aids over the years, 9 out of 10 people with mild to ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... Development and Manufacturing Organization (CDMO) with sites in China and the United ... and aseptic fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate ...
(Date:12/5/2018)... ... December 05, 2018 , ... The incredible life story of former refugee ... European Parliament by Carlos Moedas, the European Commissioner for Research and Innovation. , ... Our Daily Lives, Commissioner Moedas spoke at length of Yousef’s life and journey, citing ...
(Date:12/5/2018)... ... December 04, 2018 , ... ... North American full-service contract research organization (CRO), announced the acquisition of CCA ... strengthens ARG’s reach and experience in the management of clinical trials. , ...
Breaking Biology Technology:
(Date:12/13/2018)... SAN FRANCISCO (PRWEB) , ... December 13, 2018 ... ... life sciences, just released a must-see documentary entitled “What Researchers Need to ... Biocompare’s Reproducibility Issues in Life Science Research series. The goal of this film ...
(Date:12/10/2018)... ... December 10, 2018 , ... Today, ... advance their shared goal of accelerating the development of the Regenerative Medicine field. ... to TRT’s core technology around human umbilical cord perivascular cells (HUCPVCs). Together, ...
(Date:12/5/2018)... ... December 05, 2018 , ... Surgical Theater brings familial patient ... December 6-9, 2018 at booth #312. AANS/CNS provides Pediatric Neurosurgeons an opportunity to ... continuum – from the consultation, to surgical planning, and into the operating room. ...
Breaking Biology News(10 mins):